Aims: Autism spectrum disorder (ASD) is a wide range of neurodevelopmental disorders involving deficits in social interaction and communication. Unfortunately, autism remains a scientific and clinical challenge owing to the lack of understanding the cellular and molecular mechanisms underlying it. This study aimed to investigate the pathophysiological mechanism underlying leukocyte-endothelial adhesion in autismrelated neurovascular inflammation.
| INTRODUC TI ON
Autism spectrum disorder (ASD) is a pervasive disorder that broadly affects cognitive, social, and motor functioning. 1 To date, the lack of efficient tools for diagnosing autism (except for the checklist of autism-specific behavioral evaluation) 2, 3 and the lack of an effective approach for medical therapy in a clinical setting make investigating the field of autism-related neurological diseases an enormous challenge. 1, [4] [5] [6] [7] Autism is arguably caused by a multifaceted combination of genetic, epigenetic, and environmental neurotoxicants as well as in utero risk factors. 8, 9 This has attracted surging interest in exploring the ongoing pathological events and the one or more mechanisms underlying it. Accumulating clinical evidence suggests that notable neuroinflammation and microglial activation are observed in individuals with autistic-like behaviors, 2,10-13 and who might be suffering from neuronal malfunction associated with autism. However, a molecular understanding of these pathological events and processes remains unknown.
14 Leukocyte attachment to the vascular endothelium is a hallmark of the inflammatory process; it facilitates transendothelial migration of leukocytes into the CNS and thereby elicits neuroinflammation in different brain diseases, as previously reported, for example, multiple sclerosis, 15 atherosclerosis, 16 and septic encephalopathy. 17 In particular, the modulation pattern of leukocyte-endothelium adhesion in autistic patients has remained controversial. Several studies have found reduced levels of adhesion molecules including the soluble platelet-endothelial adhesion molecule-1 (sPECAM-1) and soluble platelet selectin (sP-selectin), which are thought to largely contribute to the attachment of leukocytes to the endothelium, which in adults will lead to high-functioning autism. [18] [19] [20] By contrast, elevated levels of another group of adhesion molecules, tissue plasminogen activator (tPA) and E-selectin, have also been reported in children with ASD. 21 Until now, the precise role and mechanism underlying brain leukocyteendothelium adhesion in ASD-related neurovascular inflammation remain largely uncharted.
The lysosomal cysteine protease cathepsin B has been implicated in pathological conditions such as tumor progression, neurodegenerative diseases, and autoimmune disorders. 22 Cathepsin B plays one of the intricate roles in the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome activation; it represents a potential target for therapeutic intervention to ameliorate inflammation. 23 Previous research indicated that the specific inhibition of cathepsin B successfully reduced aberrant inflammatory responses in a mouse model for autoimmunity and ischemia. [24] [25] [26] [27] It would be interesting to better understand the regulatory pattern of cathepsin B activity during the inflammatory process involving leukocyte and endothelium interactions in autism.
We therefore investigated the pathophysiological relevance of induced autism-related leukocyte-endothelial cell adhesion and neurovascular inflammation in a mouse model of ASD, using an inbred mouse strain, BTBR T+tf/J (herein referred to as BTBR).
The BTBR mice recapitulated well the key features of autistic-like behaviors including relatively more grooming, less reciprocal social interaction, and different ultrasonic vocalizations, which may be relevant to autism. [28] [29] [30] [31] Here, we defined the regulatory role of cathepsin B in the neurovascular inflammation of BTBR mice in vivo, whereby blockade of cathepsin B abolished enhanced leukocyte-endothelial adhesion during autism-related neurovascular inflammation, thus providing a rational framework for developing new anti-autism drugs.
| ME THODS

| Animals
Eight-to ten-week-old male adult BTBR T+tf/J (BTBR) mice were obtained from the Model Animal Research Center of Nanjing University. 32 Additionally, adult male wild-type C57BL/6J (C57) mice were used as controls in the present study. A total of 83 mice (n = 4-5 animals/group/experiment) with 22-25 g average body weight were divided into four groups: (a) C57 (n = 35 mice), (b) BTBR (n = 22 mice), (c) BTBR+saline (n = 13 mice), and (d) BTBR+CA-074Me (n = 13 mice). All animals were group-housed under standard conditions with a 12/12-hours light/dark cycle and supplied with commercial food pellets and water ad libitum.
The animal studies were approved by the Zhejiang University 
| Drug treatment
Adult male BTBR mice were treated with cathepsin B inhibitor (CA-074Me) or saline via osmotic minipumps (Alzet model 1002, small pumps: SP). An osmotic minipump was inserted into the lateral ventricle of the brain (icv) of each animal as reported. 33, 34 CA-074Me was administered at 1 mg/mL in saline with 1.5%
Me 2 SO (Sigma) at a rate of 0.2 μL/h, equivalent to an estimated dose rate of 0.013mg/day-g brain weight. 33 Animals received a continuous infusion of CA-074Me or carrier solution (saline with 1.5% Me 2 SO) for 7 days and were then evaluated in all subsequent experiments.
| Preparation of mice for TPLSM in vivo
Mice were anesthetized using chloral hydrate (400 mg/kg body weight ip) and subjected to in vivo imaging. A craniotomy window, centered by stereotaxic coordinates (2.5 mm later bregma, 2.5 mm lateral), 17, 35 was prepared for studying leukocyte adhesion. The custom-made metal frame (1 cm diameter), with a removable GOMN glass lid, was carefully fixed to the skull using glue and dental cement. 17 Low-melting agarose (1.5%, w/v) in an artificial cerebrospinal fluid configuration was used to fill the exposed brain surface and the glass cover.
| TPLSM imaging and analysis
A two-photon confocal microscope (Olympus, Ltd., Tokyo, Japan, BX61W1-FV1000), equipped with a femtosecond Ti:Sa laser excitation source and Spectra-Physics MaiTai HP DeepSee, was used to acquire a stacked or single-focal-plane two-photon image. A long working distance (2 mm) water immersion objective (×25, NA 1.05) was used to measure leukocyte movement in mouse brain vessels.
Intravenous bolus injection of rhodamine 6G solution (50 μL, 0.01%, Sigma-Aldrich) was used for the in vivo leukocyte adhesion assay.
17
By adjusting the XY axis manually and the optimal observation area containing rhodamine 6G labeling, adherent leukocytes were detected for each animal group. Subsequently, each area was scanned at a magnification (water immersion objective 25 × with or without 2 × zoom) by manually setting the XYT stacks. XYT stacks were typically collected within a scan field of 12-bit depth at 1024 × 1024 pixel resolution, a scanning speed of 2 μs/pixel, and an image acquisition time of 1 minute, in total. 17, 36 We defined "adherent" leukocytes as those leukocytes firmly attached to the endothelium and those remain in place for more than 1 minute. We selected 4-5 cortical vessels (at least five areas) with a diameter of 20-40 μm and a depth of 150 μm below the cortical surface for two-photon imaging for each mouse. The blood vessel imaging and leukocyte adhesion quantitative analysis were carried out as previously described. 17, 36 We measured the leukocyte rolling velocity for leukocytes entering the distance of view by transillumination intravital microscopy.
The diameter of cortical brain vessels was measured or determined manually using ImageJ (NIH, Bethesda, MD).
| Neutrophil isolation
The neutrophils were isolated from the peripheral blood of mice following a protocol previously described. 37 Briefly, blood was collected from the retro-orbital vein and diluted in pre-cooled K 2 -ethylenediaminetetraacetic acid (EDTA) with an equal volume of PBS.
Diluted blood (5 mL) was plated on a discontinuous gradient of 3 mL Histopaque 1119 and 3 mL Histopaque 1077 (Sigma-Aldrich).
Following centrifugation (35 minutes at 700 g), the neutrophil layer between the Histopaque 1077 and Histopaque 1119 was collected and washed in PBS. RBC lysis (BD Biosciences) was performed as above. Neutrophils were washed, counted, and resuspended according to their experimental condition.
| Cathepsin B activity assays
The cathepsin B activity of neutrophil lysates was measured using an assay kit from BioVision (Mountain View, CA). 38 This kit is a fluorescence-based assay that utilizes the preferred cathepsin B substrate sequence labeled with amino-4-trifluoromethylcoumarin (AFC). Neutrophil lysates were incubated with the cathepsin B substrate of the assay kit for 1 hour at 37°C, and the fluorescence intensity at 505 nm was measured by a fluorescence microplate reader (Beckman Coulter Inc., Brea, CA, USA).
| Cell preparation and flow cytometry analyses
We collected peripheral blood from mice before decapitation and used it for flow cytometry as described previously. 17 Endothelial cells of mouse brain were isolated as described. 17 Briefly, the cortex of the mouse brain was digested with freshly prepared Dulbecco's modi- 
| Western blotting
Neutrophils were isolated as described previously in Section 2.5. The total brain and microvessel protein extracts from the mouse cerebral cortex were prepared for Western blotting. 39 Protein samples were 
| RNA isolation and real-time quantitative RT-PCR
Mouse brain cortex endothelial cells were isolated as previously described. 17 Tissues were homogenized, and RNA was extracted using RNAiso Plus (Takara, Shiga, Japan). We synthesized cDNA by reverse transcribing 500 ng of total RNA using a reagent (Kit PrimeScript™ RT) (Takara, Shiga, Japan) according to the manufacturer's instruc- Table S1 .
| Statistics
The two group data comparisons were analyzed with a two-tailed unpaired t test (parametric data), and multi-group comparisons were by one-way analysis of variance (ANOVA), followed by a post hoc Dunnett's comparison of Tukey's test to the control. Data are shown as mean ± SEM, and significance was taken at P < 0.05.
| RE SULTS
| Two-photon imaging reveals increased leukocyte adhesion in the brain vessels of BTBR mice
Temporal and spatial fine-tuning of the leukocyte adhesion cascade was successfully observed in BTBR mice ( Figure 1A) . Importantly, the number of adherent leukocytes (firm adhesion) from BTBR mice was significantly and robustly increased from 28 ± 10 per mm 2 in
wild-type C57 mice to 779 ± 116 per mm 2 in BTBR mice (28 ± 10 per 
| Upregulation of neutrophil cathepsin B during neuroinflammation in BTBR mice
Given the inflammatory response of leukocytes and the endothelium in brain vessels, we investigated the effect of vascular inflammation on the neighboring neurons in BTBR mice. Neuroinflammation is manifested by NLRP3-inflammasome activation, resulting in increased cleavage of interleukin-1β (IL-1β). 23, 41 Therefore, we measured the expression levels of cleaved IL-1β and caspase-1 in the cortex of C57
and BTBR mice to uncover the neuronal response to the inflammatory signal in the brain. The data indicated that the neuroinflammation The data are shown as the means ±SEM from at least three independent experiments. (n = 5, per group). **P < 0.01 vs C57
indicators cleaved IL-1β and caspase-1, which were markedly increased in the cortex of BTBR mice, which coincide with enhanced leukocyte adhesion to the endothelium in BTBR mice ( Figure 4A,B) .
To obtain a deeper insight into the cause governing neurovascular inflammation in autism, we monitored neutrophil cathepsin B levels in BTBR mice. Compared to C57 mice, we found a profound elevation in both cathepsin B protein expression and cathepsin B activity in the neutrophils of BTBR mice ( Figure 4C-E) . This suggests that neutrophil cathepsin B activation could be closely related to leukocyte-endothelial adhesion and neuroinflammation response during ASD.
| Inhibition of cathepsin B suppresses leukocyte-endothelial cell adhesion in BTBR mice
Inhibition of specific leukocyte adhesion molecules could be of therapeutic value for treating brain diseases. 17 Herein, we investigated Next, we examined the inhibitory effect of CA-074Me on the levels of adhesion molecules and chemokine in BTBR mice. Flow cytometry showed that blocking cathepsin B activity by CA-074Me reduced leukocyte CD11b and endothelial ICAM-1 levels ( Figure 6A,B) .
This finding is consistent with the fact that integrin ligand ICAM-1 interacts with CD11b on leukocytes. 42 Moreover, the treatment also inhibited the elevation of endothelial chemokine CXCL7 induced in BTBR mice ( Figure 6C ). Taken together, these results suggest that neutrophil cathepsin B activation initiates leukocyte-endothelial cell adhesion by increasing adhesion molecules CD11b and ICAM-1 in BTBR mice.
| D ISCUSS I ON
In this research, we describe the importance of neutrophil cathepsin B in regulating leukocyte-endothelial cell adhesion and increasing neurovascular inflammation during autism development.
Importantly, we found that overactivation of neutrophil cathepsin B initiates leukocyte-endothelial cell adhesion, followed by leukocyte CD11b/endothelial ICAM-1 activation, a pathological process that can be suppressed by the cathepsin B inhibitor CA-074Me. Our results provide new mechanistic insights into the role of neutrophil cathepsin B in inducing neurovascular inflammation during autism.
Brain inflammation has long-term consequences and could speculatively modulate the risk for a variety of neurological disorders including autism spectrum disorders. 55, 56 In this study,our results are the same as a previous study showing that the elevation of endothelial chemokine CXCL7 plays a role in the development of neurobehavioral alterations that are triggered by various risk factors. 57, 58 Taken together, these data suggest that high levels of inflammatory cytokine and endothelial chemokine are similar to those found in the autistic-like mouse models.
More importantly, the inhibition of cathepsin B blocked NLRP3 inflammasome activation as well as effectively improved the neurological recovery of mice in brain disease, [24] [25] [26] [27] 59, 60 
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